All In Biotech

Free tool

FAERS Monitor: Desonide

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017426 or its brand name (Desonide, Desonide). Reports on generic versions are filed under their own applications.

Reports

5,063

Serious

2,770

55% of reports

Hospitalization

1,116

Death reported

196

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,209
  • macular degeneration787
  • off label use428
  • pain394
  • nausea381
  • pruritus361
  • rash339
  • headache327
  • erythema317
  • pyrexia307
  • psoriasis284
  • malaise283
  • weight decreased278
  • therapeutic product effect incomplete264
  • dermatitis atopic250

Reports by year received

View as table
YearReports
20049
200514
200621
200714
200824
200935
201027
201151
201275
2013110
2014113
2015216
2016277
2017248
2018296
2019279
2020341
2021619
2022508
2023579
2024405
2025460
2026342

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,096 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
macular degenerationSignal787292.9274.0213,753
dermatitis atopicSignal25019.817.54,430
therapeutic product effect incompleteSignal26415.513.83,558
psoriasisSignal2849.18.12,034
erythemaSignal3176.45.81,455
weight decreasedSignal2784.13.7667
pruritusSignal3613.93.5791
drug ineffectiveSignal1,2093.83.62,672
pyrexiaSignal3073.73.3608
rashSignal3393.22.9531
malaiseSignal2832.72.4303
painSignal3942.72.4420
headacheSignal3272.22.0211
off label useSignal4282.01.9233
nauseaSignal3812.01.8197

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.